We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$589M
AUM Growth
+$142M
Cap. Flow
+$127M
Cap. Flow %
21.51%
Top 10 Hldgs %
17.61%
Holding
642
New
226
Increased
94
Reduced
75
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 19.65%
2 Consumer Discretionary 17.38%
3 Healthcare 11.58%
4 Communication Services 9.88%
5 Financials 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIO icon
301
Rio Tinto
RIO
$158B
$365K 0.06%
10,940
-12,461
-53% -$397K
OTIC
302
DELISTED
Otonomy, Inc.
OTIC
$364K 0.06%
+20,000
New +$327K
E icon
303
ENI
E
$80.5B
$350K 0.06%
+12,134
New +$369K
BRK.B icon
304
Berkshire Hathaway Class B
BRK.B
$1.1T
$344K 0.06%
+2,378
New +$348K
CAR icon
305
Avis
CAR
$5.37B
$339K 0.06%
+9,904
New +$359K
AMAT icon
306
Applied Materials
AMAT
$398B
$333K 0.06%
11,058
-85,428
-89% -$2.38M
AMBA icon
307
Ambarella
AMBA
$3.25B
$331K 0.06%
+4,500
New +$282K
CPE
308
DELISTED
Callon Petroleum Company
CPE
$331K 0.06%
2,105
+498
+31% +$65.9K
SCHW
309
Charles Schwab
SCHW
$181B
$326K 0.06%
10,334
-46,234
-82% -$1.36M
GD icon
310
General Dynamics
GD
$103B
$318K 0.05%
+2,047
New +$305K
CPAY icon
311
Corpay
CPAY
$25.5B
$317K 0.05%
1,823
-5,580
-75% -$894K
BJRI icon
312
BJ's Restaurants
BJRI
$1.56B
$306K 0.05%
+8,623
New +$347K
LULU icon
313
lululemon athletica
LULU
$13.6B
$306K 0.05%
5,025
+763
+18% +$56.3K
ALDR
314
DELISTED
Alder Biopharmaceuticals
ALDR
$305K 0.05%
9,321
+106
+1% +$3.23K
ENTA icon
315
Enanta Pharmaceuticals
ENTA
$378M
$303K 0.05%
11,376
-3,639
-24% -$84.5K
ON icon
316
ON Semiconductor
ON
$32.6B
$299K 0.05%
24,219
+13,895
+135% +$144K
TBRG
317
DELISTED
TruBridge
TBRG
$296K 0.05%
+11,338
New +$356K
TRIL
318
DELISTED
Trillium Therapeutics Inc.
TRIL
$296K 0.05%
20,000
QCOM icon
319
Qualcomm
QCOM
$159B
$295K 0.05%
+4,312
New +$262K
GSK icon
320
GSK
GSK
$104B
$294K 0.05%
5,454
+474
+10% +$26K
NERV icon
321
Minerva Neurosciences
NERV
$187M
$289K 0.05%
+2,560
New +$248K
MGM icon
322
MGM Resorts International
MGM
$11.7B
$285K 0.05%
10,958
-73,976
-87% -$1.8M
ESPR
323
DELISTED
Esperion Therapeutics
ESPR
$278K 0.05%
+20,062
New +$227K
FTV icon
324
Fortive
FTV
$17.7B
$277K 0.05%
+8,636
New +$277K
NBIX icon
325
Neurocrine Biosciences
NBIX
$18.7B
$274K 0.05%
5,419
-81,244
-94% -$4.05M

Similar funds

Schonfeld Strategic Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Schonfeld Strategic Advisors held 642 positions worth $589M, up 32% from $447M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Schonfeld Strategic Advisors deployed $127M of net new capital in Q3 2016, opening 226 new positions and adding to 94 existing holdings. Its largest new stake was CyrusOne Inc Common Stock: 294,137 shares worth $14M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Uniti Group, an estimated $7.55M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2016 buy was CyrusOne Inc Common Stock: 294,137 shares worth $14M.
  • Schonfeld Strategic Advisors added most to Amazon in Q3 2016, an estimated $12.7M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2016 reduction was Uniti Group, cutting an estimated $7.55M.
  • Schonfeld Strategic Advisors fully exited Charter Communications in Q3 2016, selling an estimated $12.7M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 18% of its $589M portfolio in Q3 2016.
  • Schonfeld Strategic Advisors opened 226 new positions and closed 242 in Q3 2016.
  • Schonfeld Strategic Advisors's portfolio value rose 32% quarter-over-quarter to $589M.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.